160 related articles for article (PubMed ID: 23935951)
1. Exploring the mode of action of bioactive compounds by microfluidic transcriptional profiling in mycobacteria.
Murima P; de Sessions PF; Lim V; Naim AN; Bifani P; Boshoff HI; Sambandamurthy VK; Dick T; Hibberd ML; Schreiber M; Rao SP
PLoS One; 2013; 8(7):e69191. PubMed ID: 23935951
[TBL] [Abstract][Full Text] [Related]
2. Use of DNA arrays to study transcriptional responses to antimycobacterial compounds.
Waddell SJ; Butcher PD
Methods Mol Biol; 2010; 642():75-91. PubMed ID: 20401587
[TBL] [Abstract][Full Text] [Related]
3. [The effect of emetine hydrochloride on the growth of different mycobacteria strains].
Schwartz E
Zentralbl Bakteriol Orig; 1969 Dec; 212(1):115-25. PubMed ID: 4989350
[No Abstract] [Full Text] [Related]
4. Disinfective process of strongly acidic electrolyzed product of sodium chloride solution against Mycobacteria.
Yamamoto TM; Nakano T; Yamaguchi M; Shimizu M; Wu H; Aoki H; Ota R; Kobayashi T; Sano K
Med Mol Morphol; 2012 Dec; 45(4):199-205. PubMed ID: 23224598
[TBL] [Abstract][Full Text] [Related]
5. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis.
Mailaender C; Reiling N; Engelhardt H; Bossmann S; Ehlers S; Niederweis M
Microbiology (Reading); 2004 Apr; 150(Pt 4):853-864. PubMed ID: 15073295
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis.
Colangeli R; Helb D; Vilchèze C; Hazbón MH; Lee CG; Safi H; Sayers B; Sardone I; Jones MB; Fleischmann RD; Peterson SN; Jacobs WR; Alland D
PLoS Pathog; 2007 Jun; 3(6):e87. PubMed ID: 17590082
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.
Zhang Y; Dhandayuthapani S; Deretic V
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13212-6. PubMed ID: 8917570
[TBL] [Abstract][Full Text] [Related]
8. Effect of silver-carrying photocatalyst "Hikari-Gintech" on mycobacterial growth in vitro.
Matsui Y; Otomo K; Ishida S; Yanagihara K; Kawanobe Y; Kida S; Taruoka E; Sugawara I
Microbiol Immunol; 2004; 48(7):489-95. PubMed ID: 15272193
[TBL] [Abstract][Full Text] [Related]
9. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in mycobacteria: transcriptional fusions based on xylE and analysis of the promoter region of the response regulator mtrA from Mycobacterium tuberculosis.
Curcic R; Dhandayuthapani S; Deretic V
Mol Microbiol; 1994 Sep; 13(6):1057-64. PubMed ID: 7854120
[TBL] [Abstract][Full Text] [Related]
11. Peptide deformylase inhibitors as potent antimycobacterial agents.
Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
[TBL] [Abstract][Full Text] [Related]
12. Global transcriptional response to vancomycin in Mycobacterium tuberculosis.
Provvedi R; Boldrin F; Falciani F; Palù G; Manganelli R
Microbiology (Reading); 2009 Apr; 155(Pt 4):1093-1102. PubMed ID: 19332811
[TBL] [Abstract][Full Text] [Related]
13. Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.
Naran K; Moosa A; Barry CE; Boshoff HI; Mizrahi V; Warner DF
Antimicrob Agents Chemother; 2016 Nov; 60(11):6748-6757. PubMed ID: 27572410
[TBL] [Abstract][Full Text] [Related]
14. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
16. cDNA-RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG.
Li MS; Monahan IM; Waddell SJ; Mangan JA; Martin SL; Everett MJ; Butcher PD
Microbiology (Reading); 2001 Aug; 147(Pt 8):2293-2305. PubMed ID: 11496006
[TBL] [Abstract][Full Text] [Related]
17. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of
Madani A; Ridenour JN; Martin BP; Paudel RR; Abdul Basir A; Le Moigne V; Herrmann JL; Audebert S; Camoin L; Kremer L; Spilling CD; Canaan S; Cavalier JF
ACS Infect Dis; 2019 Sep; 5(9):1597-1608. PubMed ID: 31299146
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel scaffolds targeting Mycobacterium tuberculosis.
Dal Molin M; Selchow P; Schäfle D; Tschumi A; Ryckmans T; Laage-Witt S; Sander P
J Mol Med (Berl); 2019 Nov; 97(11):1601-1613. PubMed ID: 31728550
[TBL] [Abstract][Full Text] [Related]
20. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
